
Vyshak Venur, MD
@venurvyshak
Neuro-Oncologist | @UWMedicine | @FredHutch. Interested in clinical research in CNS tumors and metastases. Tweets are my own. #btsm
ID: 1178573477374128128
https://www.seattlecca.org/providers/vyshak-venur 30-09-2019 07:33:17
139 Tweet
367 Followers
803 Following

Listen to Dr. Gentili's harrowing story! bit.ly/drgentili #Neurosurgery gelareh-zadeh




Led by our stellar University of Washington Radiation Oncology resident Joseph Tsai- Management of brain metastases from gestational trophoblastic neoplasia, a rare entity. Vyshak Venur, MD Heidi Gray, MD Matt foote arjun sahgal Bala Vellay Joshua D. Palmer, MD Prof. Dr. Stephanie Combs



Thanks for the shout out PDBrown. Excited about preliminary results and looking forward to randomized phase 2 -SURVIVE currently enrolling! clinicaltrials.gov/ct2/show/NCT05… @platten_michael Michael Ciesielski @MimiVaxLLC Vyshak Venur, MD @nbutowski OncoAlert Journal of Clinical Oncology

Finally a positive phase 3 study for patients with low grade glioma, who are often young at diagnosis.Will meaningfully delay chemo and RT! Lynne P. Taylor, M.D. Manmeet Ahluwalia, MD, MBA, FASCO Mustafa Khasraw (find me in BlueSky) MJ Lim-Fat Simon Lo servier.us/serviers-pivot…

Best part of ASCO is meeting your friends and colleagues from prior years who helped shape your career Brian Rini, MD Nathan A. Pennell MD, PhD, FASCO Cleveland Clinic Cleveland Clinic MD


Ingo Mellinghoff Memorial Sloan Kettering Cancer Center presented Vorasidenib - oral inhibitor of IDH1 & 2 in low grade gliomas ASCO PFS benefit in Vorasidenib at 27.7 mth vs to 11.1 mth in placebo gp. Time to next treatment also increased. New option for low grade gliomas w IDH mutation! #ASCO2023


I'm thrilled to welcome Dr. Sara Hurvitz to Fred Hutchinson Cancer Center and UW Department of Medicine. Sara is the right leader to bring together our hematology and oncology divisions, accelerate research and advance education with the goal of improving care for our patients. bit.ly/3Na2ut7

Register now for CORC 2023! uw.cloud-cme.com/MJ2401 Fred Hutch Cancer Center UW Medicine #hematology #oncology Rahul Banerjee, MD, FACP @Zcerminara Petros Grivas William R Gwin III, MD Evan Hall Ang Li, MD, MS @CPR_Seattle Mazyar Shadman, MD MPH Veena Shankaran MD, MS @smithMD18 Vyshak Venur, MD @zamora_danniel



Fantastic best of ASCO talk by Vyshak Venur, MD Fred Hutch Cancer Center on brain tumors: lot of development in aggressive cancers, great to work with Vyshak & see his rapid career growth! Manmeet Ahluwalia, MD, MBA, FASCO Michael Wagner Rahul Banerjee, MD, FACP Mazyar Shadman, MD MPH Jessica Hawley MD MS Beyond Trauma Foundation Binay Shah, MD, MHA Dimitra R. Bakaloudi MD, MS, MPA


Incredible general #oncology session w/ Michael Wagner (Dana-Farber), Dr. Paul Swiecicki (Michigan Medicine), and Vyshak Venur, MD & Dr. Kalyan Banda of UW Medicine/Fred Hutch Cancer Center here in 📍Seattle #BestofASCO24!


Fantastic weekend indeed! Thanks Beyond Trauma Foundation Binay Shah, MD, MHA & staff for the opportunity to co-chair with Dave Zhen! Amazing sessions, learning, format, speakers! Fred Hutch Cancer Center Dr. Tom Lynch Rahul Banerjee, MD, FACP Mazyar Shadman, MD MPH Michael Wagner Vyshak Venur, MD Jessica Hawley MD MS ASCO Julie Gralow Eric J. Small, MD, FASCO


Dr. Vyshak Venur, MD sharing his expertise and important updates in management of CNS malignancies Beyond Trauma Foundation Boise.

